Abstract
We studied the responses of smokers and life-long non-smokers to transdermal nicotine patches over 24 h in three groups of subjects: non-smokers on a 15 mg patch (n=8), non-smokers on a 30 mg patch (n=8) and smokers on a 30 mg patch (n=8). Unexpectedly, the non-smokers appeared to absorb nicotine more rapidly. The increase in blood nicotine concentrations of non-smokers over the first 2 h of patch use was double that of the smokers, with mean increases of 4.5 (SD=3.7), 10.9 (SD=4.2) and 4.1 (SD=2.7) ng/ml in the three groups, respectively (P<0.005). The smokers had no pleasant or unpleasant effects from the 30 mg patch (\(\bar X\) Cmax 13.9 ng/ml, SD=4.9; Tmax 8.75 h) but all eight non-smokers experienced mild nausea and lightheadedness (P<0.01) within the first hour, and seven dropped out (P<0.01) at 3–8 h due mainly to severe nausea, vomiting or headache (\(\bar X\) Cmax 18.4 ng/ml, SD=4.9; Tmax 5.25 h). Only one non-smoker dropped out on the 15 mg patch, but five had transient nausea in the first hour (\(\bar X\) Cmax 7.9 ng/ml, SD=3.0; Tmax 8.0). Our study provides evidence of chronic pharmacodynamic nicotine tolerance in smokers, but does not address whether this is acquired or innate. The higher rate of transdermal nicotine absorption in non-smokers is unexplained and requires replication.
Similar content being viewed by others
References
Abelin T, Muller P, Buehler A et al. (1989) Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1:7–10
Bannon YB, Corish J, Corrigan OI et al. (1989) Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study. Eur J Clin Pharmacol 37:285–290
Beckett AH, Gorrod JW, Jenner P (1971) Effect of smoking on nicotine metabolism in vivo in man. J Pharm Pharmacol 23:Suppl 62S-67S
Beckett AH, Triggs EJ (1967) Enzyme induction in man caused by smoking. Nature 216:587
Benowitz NL (1988) Pharmacologic aspects of cigarette smoking and nicotine addiction. New Eng J Med 319:1318–1330
Benowitz NL, Jacob P, Jones RT, Rosenberg J (1982) Interindividual variability in metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 221:368–372
Benwell MEM, Balfour DJK, Anderson JM (1988) Evidence that tobacco smoking increases the density of nicotine binding sites in human brain. J Neurochem 50:1243–1247
Clarke PBS (1987) Nicotine and smoking: a perspective from animal studies. Psychopharmacology 92:135–143
Dubois JP, Sioufi A, Muller P et al. (1989) Pharmacokinetics and bioavailability of nicotine in healthy volunteers following single and repeated administration of different doses of transdermal nicotine systems. Methods Find Exp Clin Pharmacol 11:187–195
Feyerabend C, Russell MAH (1990) A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol 42:450–452
Fuxe K, Andersson K, Eneroth P et al. (1989) Neurochemical mechanisms underlying the neuroendocrine actions of nicotine: focus on the plasticity of central cholinergic nicotinic receptors. Prog Brain Res 79:197–207
Harries AD, Baird A, Rhodes J (1982) Non-smoking: a feature of ulcerative colitis. Br Med J 284:706
Kellar KJ, Giblin BA, Lumpkin MD (1989) Regulation of nicotinic cholinergic recognition sites and prolactin release by nicotine. Prog Brain Res 79:209–216
Kyerematen GA, Damiano MD, Dvorchik BH, Vesell ES (1982) Smoking-induced changes in nicotine disposition: application of a new HPLC assay for nicotine and its metabolites. Clin Pharmacol Ther 32:769–780
Langley JN, Dickinson WL (1889) On the local paralysis of peripheral ganglia, and on the connection of different classes of nerve fibres with them. Proc R Soc Lond 46:423–431
Marks MJ, Romm E, Gaffney DK, Collins AC (1986) Nicotine-induced tolerance and receptor changes in four mouse strains. J Pharmacol Exp Ther 237:809–819
Morrison CF, Stephenson JA (1972) The occurrence of tolerance to a central depressant effect of nicotine. Br J Pharmacol 46:141–146
Motley RJ, Rhodes J, Kay S, Morris TJ (1988) Late presentation of ulcerative colitis in ex-smokers. Int J Colorect Dis 3:171–175
Mulligan SC, Masterson JG, Devane JG, Kelly JG (1990) Clinical and pharmacokinetic properties of a transdermal nicotine patch. Clin Pharmacol Ther 47:331–337
Murphree HD (1979) EEG effects in humans of nicotine, tobacco smoking, withdrawal from smoking and possible surrogates. In: Redmond A, Izard C (eds) Electrophysiological effects of nicotine. Elsevier, Amsterdam, pp 227–243
Porchet HC, Benowitz NL, Sheiner LB (1988) Pharmacodynamic model of tolerance: application to nicotine. J Pharmacol Exp Ther 244:231–236
Rudra T, Motley RJ, Rhodes J (1989) Does smoking improve colitis? Scand J Gastroenterol 24 [suppl 170]: 61–63
Russell MAH (1988) Nicotine replacement: the role of blood nicotine levels, their rate of change, and nicotine tolerance. In: Pomerleau OF, Pomerleau CS (eds) Nicotine replacement: a critical evaluation. Liss, New York, pp 63–94
Russell MAH, Jarvis MJ, Jones G, Feyerabend C (1990) Non-smokers show acute tolerance to subcutaneous nicotine. Psychopharmacology 102:56–58
Schwartz RD, Kellar KJ (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220:214–216
Sharp BM, Beyer HS (1986) Rapid desensitisation of the acute stimulatory effects of nicotine on plasma adrenocorticotropin and prolactin. J Pharmacol Exp Ther 238:486–491
Stolerman IP, Fink R, Jarvik ME (1973) Acute and chronic tolerance to nicotine measured by activity in rats Psychopharmacologia 30:329–342
West RJ, Jarvis MJ (1986) Effects of nicotine on finger tapping rate in non-smokers. Pharmacol Biochem Behav 25:727–731
West RJ, Russell MAH (1987) Cardiovascular and subjective effects of smoking before and after 24 h abstinence from cigarettes. Psychopharmacology 92:118–121
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Srivastava, E.D., Russell, M.A.H., Feyerabend, C. et al. Sensitivity and tolerance to nicotine in smokers and nonsmokers. Psychopharmacology 105, 63–68 (1991). https://doi.org/10.1007/BF02316865
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02316865